A large Phase 2b/3 adaptive design induction and maintenance study of TD-1473 in ulcerative colitis.
Phase of Trial: Phase II/III
Latest Information Update: 27 Feb 2018
At a glance
- Drugs TD 1473 (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 27 Feb 2018 According to a Theravance Biopharma media release, this study is expected to begin in second half of 2018.
- 11 Aug 2017 New trial record
- 08 Aug 2017 According to a Theravance Biopharma media release, this study is expected tp begin in 2018.